L ow back pain (LBP) is common with a lifetime incidence of up to 80% 1 , 2 ; 5% to 20% develop more persistent chronic low back pain (CLBP). 3 -6 Health care costs are consequently substantial. 7 -9 Although national 10 and international guidelines 11 recommend exercise therapy in the management of CLBP, the longterm effectiveness of such an approach seems minimal. 12 , 13 The equivocal nature of research may be due to patient heterogeneity. CLBP may represent different subgroups that may respond differently to different treatments. 14 , 15 Assessing these subgroups together as one homogeneous group may dilute specifi c treatment effects, hence explaining the minimal observed benefi t of exercise in clinical trials. Consequently, novel approaches yet to be investigated in robust randomized controlled trials have been proposed 16 , 17 as alternatives and possibly effective adjuncts to LBP management.
Results. At 12 months, data from 44 of 58 (77.2%) of the rocker sole group and 49 of 57 (84.5%) of the fl at sole group were available for analysis. In the rocker sole group, mean reduction in RMDQ was − 3.1 (95% CI [confi dence interval], − 4.5 to − 1.6), and in the fl at sole group, it was − 4.4 (95% CI, − 5.8 to − 3.1) (a greater negative value represents a greater reduction in disability). At 6 months, more people wearing fl at shoes compared with those wearing rocker shoes demonstrated a minimal clinically important improvement in disability (53.2% and 31.1%, respectively; P = 0.03). Betweengroup differences were not signifi cant for RMDQ or any secondary outcomes ( e . g ., pain) at any time. People reporting pain when standing and walking at baseline (n = 59) reported a greater reduction in RMDQ at 12 months in the fl at sole group ( − 4.4 [95% October 2013 Rocker sole footwear have been marketed with persuasive advertising suggesting that use of this footwear leads to a reduction in LBP. 18 Manufacturers claim that the unstable curved sole can positively infl uence mechanisms associated with CLBP, such as poor balance, substandard muscle function, poor posture, and reduced capacity to attenuate shock while walking. 17 However, there is no evidence in the literature supporting these claims.
The primary aim of this randomized clinical trial was to assess whether wearing rocker sole shoes would result in an improvement in disability and reduction in pain when compared with wearing fl at sole shoes during a typical exercise treatment for CLBP. The primary hypothesis being that the addition of rocker sole shoes to the treatment of CLBP will result in a signifi cant reduction in disability (Roland Morris Disability Questionnaire [RMDQ]) in patients with CLBP when compared with the addition of fl at sole shoes when assessed at 6 weeks, 6 months, and 1 year (primary end point). A secondary aim was to determine whether people whose LBP was aggravated predominately through standing or walking would gain a greater reduction in disability if they wore rocker sole shoes than fl at sole shoes. The secondary hypothesis states that, for the subgroup of people reporting pain while standing or walking, there will be a better outcome for disability in people wearing rocker sole shoes than those wearing fl at sole shoes at 6 weeks, 6 months, and 1 year.
MATERIALS AND METHODS

Design
This was a multicenter, assessor-blind, randomized, clinical trial conducted through 4 publicly funded secondary care hospital physiotherapy departments and one private physiotherapy department in London, the United Kingdom.
Participant Recruitment
Ethical approval was obtained from the Riverside Research Ethics Committee (09/H0706/4). One hundred fi fteen participants with CLBP referred from general practitioners and consultants were recruited. Eligible participants were aged 18 to 65 years with a 3-month or greater history of LBP. Exclusion criteria were constant LBP; specifi c spinal medical diagnosis inappropriate for physiotherapy interventions, for example spinal fracture or infection; inappropriate to wear rocker sole shoes in accordance with footwear company (Masai GB Limited, London, United Kingdom) recommendations, for example peripheral neuropathy, history of falls, Morton neuroma; inappropriate for exercise physiotherapy, for example severe cardiovascular or metabolic disease preventing participation in the exercise group; participants who had previously used rocker sole shoes.
Consent and Randomization
Study participants provided informed consent prior to entry into the study and were assigned by block randomization (blocks of 4) into their allocated group. The chief investigator remained blind to group allocation for the duration of the study. Five separate randomization sheets, one for each site, each with a total of 60 potential participant group allocations (15 blocks of 4, randomly selected by M.M.) were produced and stored on a password-protected computer at each site.
Interventions
Participants were given either a pair of rocker sole shoes (Masai Barefoot Technology [MBT] Chapa Caviar, Masai GB Limited, London, United Kingdom) or fl at sole shoes (Gel 1140, ASICS, Warrington, United Kingdom) ( Figure 1 ). Company logos were removed from both shoe types. Coresearchers at each site (trained by a representative from MBT GB Ltd in correct rocker sole shoe fi tting and walking techniques) fi tted participants with their allocated footwear and educated participants on correct standing and walking technique for their allocated footwear (approximately 30-minute duration). The same amount of time was spent to train the fl at sole shoe wearers to wear their allocated shoes.
To reduce the occurrence of ailments associated with wearing a new pair of shoes, for example blisters, participants were instructed to increase the time gradually for which study shoes were worn each day, initially from 15 to 30 minutes, progressing to a minimum wear of 2 hours per day while standing and walking by the end of the fi rst week. Participants were instructed to wear their assigned shoes for periods of time totaling a minimum of 2 hours every day, for the duration of the follow-up period (1 yr).
One week after getting accustomed to the footwear, participants attended the LBP exercise group. The exercise group (a recommended treatment for patients with CLBP 10 , 19 ) lasted approximately for a duration of 1 hour, once a week, for 4 weeks. The exercise program involved a 5-minute warm up, 10 exercises (see Supplemental Digital Content Appendix, available at http://links.lww.com/BRS/A809 ), a 5-minute cool down and a 10-minute education session ("Managing a fl are up," "Pain," "Exercise," and "Relaxation" according to research recommendations for the management of CLBP, 10 , 21 while considering available space, equipment, and class duration time at each site. The exercises aimed to improve the strength of limb and trunk muscles and increase cardiovascular fi tness, in addition to specifi c trunk muscle exercises. Study participants wore their study shoes during the exercise group.
Outcomes
Participants were assessed at baseline, 6 weeks, 6 months, and 1 year. Outcome measures completed at baseline were the RMDQ 22 (primary outcome), Numerical Rating Scale for pain, 23 EQ-5D-3L Health Questionnaire (a measure of healthrelated quality of life), 24 Tampa Scale of Kinesiophobia 25 (fear avoidance questionnaire), Hospital Anxiety and Depression Questionnaire, 26 and Patient-Specifi c Functional Scale. 27 In addition, at 6 weeks, participants reported the time spent per day in the study shoes (this was recorded daily by each participant from baseline to 6-week assessment in a diary), and at 6 months and 1 year (primary outcome point), participants additionally reported the number of days taken off work because of LBP in the past 6 months, and satisfaction with their study shoes.
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Sample Size Calculation
For a power of 0.9 and an α of 0.01 based on a standard deviation of 5 (pilot study data from 20 participants) and an ability to detect a 4-point change in the mean RMDQ scores between baseline and reassessment, 29 the number of participants needed for each of the groups equaled 47. This was increased to 60 for an anticipated 20% participant loss to follow-up and missing data. Therefore, it was anticipated that 120 participants were required.
Adverse Events
Adverse events were defi ned as an increase in pain or symptoms within 1 week of commencing an intervention requiring general practitioner or casualty consultation. 
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Statistical Analysis
The primary analysis was by intention-to-treat method, including all eligible randomized participants who provided follow-up data. Two-way mixed model (between-within) analysis of variances were conducted with one within-subject factor (assessment time points) and one between-group factor (footwear type) to compare the effectiveness of footwear type over time. Analysis of variance used data from participants with complete data sets for all 4 time points (rocker sole shoe group n = 40, fl at sole shoe group n = 43) unless otherwise stated. A sensitivity analysis used "expectationmaximization" to impute missing values. Analysis of covariance, with baseline data for the primary outcome (RMDQ) from each group as the covariate, compared the effects of treatment at each reassessment point. A χ 2 test assessed differences between the groups regarding numbers reporting minimal clinical important differences in disability (greater than or equal to a 4-point improvement in the RMDQ 29 ). One preplanned subgroup analysis was conducted. Data from participants reporting pain aggravated by standing or walking on the Patient-Specifi c Functional Scale at baseline were analyzed using 2-way mixed model analysis of variance, to determine whether shoe allocation infl uenced disability in this subgroup. Data were analyzed using IBM SPSS version 20.0.0 (IBM, Armonk, New York). Results are presented as means (standard deviations) unless otherwise stated.
RESULTS
One hundred fi fteen participants were recruited into the study from April 2009 to November 2010. There were no differences between the groups in demographic data or outcome measures ( Table 1 ) at baseline; however, there was a tendency toward an increased disability (RMDQ) in the fl at sole shoe group.
Participant attrition and retention during the study are presented in Figure 2 . At 12 months, 93 (81%) participants were reassessed. There was no difference between the groups in retention at 12 months.
Both groups reported reductions in disability at each time point when compared with baseline ( P < 0.01 fl at sole group, P < 0.001 rocker sole group) ( Table 2 ; Figure 3 ). There were no differences between the groups at any follow-up point.
Disability was not different between the groups at any time point, taking into account baseline disability (analysis of covariance) ( P = 0.58) or after missing number imputation ( P = 0.13).
A greater proportion of participants allocated to wear fl at sole shoes (53%) than those allocated to the rocker sole group (31%) reported a minimal clinically important improvement at 6 months ( P = 0.03). There were no differences between the groups at 6 weeks (P = 0.56) or 12 months (P = 0.24).
Flat sole shoe wearers in the subgroup reporting pain while standing and walking showed a greater improvement in disability than the rocker sole shoe wearers at 6 weeks ( − 3. 
Flat sole shoe group
Total randomized (n = 58) 58 (100%) received allocated intervention
Rocker sole shoe group
Total randomized (n = 57) 57 (100%) received allocated intervention
6-week followup
Total completing data collection (n = 50)
• Completed intervention (n = 50)
• Did not complete intervention (n = 0) Total lost to follow-up (n = 8)
• 2 unable to attend assessment • 5 unable to contact • 1 withdrew due to time commitments
6-month followup
Total completing data collection (n = 47)
• Completed intervention (n = 41)
• Did not complete intervention (n = 6) Total lost to follow-up from baseline (n = 11)
• 4 unable to attend assessment • 6 unable to contact • 1 withdrew due to time commitments
12-month followup
Total completing data collection (n = 49)
• Completed intervention (n = 42)
• Did not complete intervention (n = 7) Total lost to follow-up from baseline (n = 9)
• 8 unable to contact • 1 withdrew due to time commitments
6-week followup
• Completed intervention (n = 49)
• Did not complete intervention (n = 1) Total lost to follow-up (n = 7)
• 1 unable to attend assessment • 4 unable to contact • 1 withdrew due to blister from shoe wear • 1 withdrew due to fear of blisters (diabetic)
6-month followup
Total completing data collection (n = 45)
• Completed intervention (n = 38)
• Did not complete intervention (n = 7) Total lost to follow-up from baseline (n = 12)
• 3 unable to attend assessment • 7 unable to contact • 1 withdrew due to blister from shoe wear • 1 withdrew due to fear of blisters (diabetic)
12-month followup
Total completing data collection (n = 44)
• Completed intervention (n = 32)
• Did not complete intervention (n = 12) Total lost to follow-up from baseline (n = 13)
• 11 unable to contact • 1 withdrew due to blister from shoe wear to − 0.4], respectively; P = 0.04) ( Figure 4 ). There was no between-group difference at any time point in the subgroup of participants who did not report pain while standing and walking ( P = 0.48).
Both groups reported reductions in their Numerical Rating Scale for pain intensity at each time point when compared with baseline ( P < 0.01). At 12 months, the fl at sole group demonstrated a 2.7-point reduction (SD, 2.7), and the rocker sole group demonstrated a 2.3-point reduction (SD, 2.8) in Numerical Rating Scale for pain. There were no differences between the groups for secondary outcomes investigating fear of movement, spinal impairment, days off work, healthrelated quality of life, patient-specifi c functional activity, and anxiety and depression, when compared at any follow-up point ( Table 2 ) .
At 6 and 12 months, participants in the fl at sole shoe group were more satisfi ed with the shoe they received than participants in the rocker sole shoe group (at 6 mo, 62% and 37%, respectively; ( P = 0.02) and at 12 mo, 73% and 46%, respectively; ( P = 0.01) were very or extremely satisfi ed). No signifi cant differences between the groups at the 3 reassessment points were noted for reported adherence to shoe use protocol. ( Continued )
Adverse Events
No serious adverse events were reported. In the rocker sole shoe group, one participant withdrew from the study in the fi rst week because of blister formation, and one participant, who was diabetic, withdrew because of a fear of blister formation from the new footwear.
the fl at sole than in the rocker sole group ( P = 0.02 and P = 0.04, respectively). At both 6 months and 12 months, participants in the fl at sole group were more satisfi ed than the participants in the rocker sole group with the shoe they received ( P = 0.02 and P = 0.01, respectively). The only published randomized controlled trial investigating rocker sole footwear in LBP 31 reported a nonclinically important reduction in pain in male golfers at 6 weeks compared with those who wore normal footwear. This fi nding concurs with the absence of clinical improvement in pain in this study in either group at 6 weeks.
While standing, individuals with CLBP demonstrate greater postural instability than people without, 32 -34 suggesting that, if a cause-effect relationship exists, reducing this postural instability may reduce LBP and associated disability. Rehabilitation of postural instability with proprioceptive or balance training has been shown to be a successful treatment in other regions of the body. 35 , 36 Although rocker sole shoes have been suggested to reduce postural instability, 37 this research indicates that for those reporting LBP while standing and walking, the use of rocker sole shoes, introducing additional postural instability, results in a poorer recovery than when fl at sole shoes are worn. In this subgroup, reporting LBP while standing and walking, the use of rocker shoes may present too great a challenge to the postural control system. The presence of pain has been associated with inhibition and delayed contraction of trunk muscles, 38 , 39 and may detrimentally affect the initiation of appropriate balance strategies. 33 For the subgroup analyzed, the addition of an unstable standing surface to a pre-existing ineffi cient postural control system 32 -34 may be detrimental, and account for the less good outcome observed in the rocker sole group.
Though not signifi cantly different, baseline mean disability was lower in the rocker sole than the fl at sole group. However, when taking into account the effect of baseline disability score (analysis of covariance), differences between the groups for changes in disability between the groups at reassessment remained nonsignifi cant.
Although differences between the groups for the primary outcome were demonstrated for the subgroup analysis at 6 weeks and 12 months, and for minimal clinically important difference at 6 months, no between-group differences for the primary outcome were demonstrated at primary end point for the intention-to-treat analysis. It is possible that clinical differences did occur between the groups at this point, but were not detected by the primary outcome. Although the main outcome measure assessed disability, a range of recommended measures, sensitive to clinical change in CLBP 40 , 41 were additionally completed. There were no differences between the groups for any of the clinical outcome questionnaires assessed. This adds strong support to the study conclusions that clinical difference between the groups did not occur at primary end point.
People with conditions such as LBP may seek medical interventions at the peak of their symptoms, 42 and that natural improvement may follow. Although both groups in this study showed improvement in reported disability at 12 months, 
➢ Key Points
Rocker sole shoes seem to be no more benefi cial than fl at sole shoes in aff ecting disability and pain outcomes in people with CLBP. If a person's CLBP is predominately aggravated by standing or walking it may be more benefi cial to wear fl at sole shoes than rocker sole shoes. A greater proportion of participants who wore the fl at sole shoes reported a clinically important change in self-reported disability at 6 months. At both 6 months and 12 months, participants in the fl at sole shoe group were more satisfi ed than the participants in the rocker sole shoe group with the shoe they received.
without the presence of a control group, it is not possible to conclude whether the observed improvement resulted from the initial effects of exercise, the prolonged use of footwear, changes in psychological factors, 43 or natural improvement. 44 The provision of footwear introduced the potential for a placebo effect 45 in both groups. Because of media reports and marketing relating to rocker shoes during the trial, the infl uence of a placebo effect may have favored those in the rocker sole group. 46 However, due to the lack of difference observed in this study between the groups, if a positive placebo effect did infl uence the rocker sole group it may have been too small to result in between-group differences or may have been negated by other variables, such as a biomechanical infl uence.
Results obtained from completion of the study diary sheets relied on accurate self-reporting of shoe use from participants. It is acknowledged that this method of reporting may not be accurate with a tendency to overestimate adherence by approximately 10%. 47 However, there does not seem to be a reason why those in the rocker sole shoe group would be more prone to inaccurate recall of such data than those in the fl at sole shoe group; hence, any inaccurate reporting is unlikely to bias the results.
Although not signifi cant, a larger proportion of participants not completing the study had been allocated to the rocker sole group. Rocker sole use may in some way be accountable for this increased drop-out rate. Two subjects allocated to the rocker sole group withdrew within the fi rst week because of a shoe-related foot blister or the fear of getting a foot blister. Other possible explanations for the tendency to greater attrition from the rocker sole group include: diffi culties adapting to walking with rocker sole shoes, impracticalities of wearing rocker sole style of shoes, and diffi culties adjusting to the additional weight of the rocker sole shoes (which were approximately twice the mass of the fl at sole shoes). The lower participant satisfaction scores and greater number of participants lost to follow-up in the rocker sole group suggest that the rocker sole shoes were less acceptable. Investigating the possible infl uence of patients' opinion or thoughts about the shoes received, in addition to patients' baseline preference of shoe design and color, may have further informed study fi ndings.
Inclusion into the study did not depend on a set threshold score on the RMDQ (primary outcome). A minimal clinically important difference of 4 points 29 has been described for the RMDQ; hence, a score of 4 points or greater at baseline may have been an appropriate inclusion criteria to enable all participants the potential to demonstrate a clinically important change.
CONCLUSION
On the basis of the fi ndings of this randomized clinical trial, clinicians should be confi dent to advise patients with CLBP that wearing either rocker sole shoes or fl at sole shoes may offer similar outcomes in disability and pain. However, if a patient reports LBP when standing or walking, it may be more benefi cial to wear fl at sole shoes than rocker sole shoes.
